Columbus Acquisition Corp/Cayman Islands
COLAAnalytical Summary
On an absolute basis, Columbus Acquisition Corp/Cayman Islands shows weak fundamentals, weighed down by Return on Invested Capital and FCF / Net Income. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.
9-Year Financial Trajectory
Quarterlyinfo Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.
Bullish Indicators
- No bullish signals detected.
Bearish Risks
- Return on Invested CapitalReturn on Invested Capital of -417.2% is weak on an absolute basis (target > 10%)
- FCF / Net IncomeFCF / Net Income of -0.45x is weak on an absolute basis (target > 1x)
Health Breakdown
Statement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ |
|---|---|---|---|---|---|---|---|---|---|
| Net Income Growth YoY (%) |
-59.0%
Weak
Weak
Year-over-year change in net income |
N/M | N/M | N/M | N/M | — | — | — | — |
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ |
|---|---|---|---|---|---|---|---|---|---|
| FCF / Net Income (x) |
-4.55x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
-0.88x
Weak
↑
Weak
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-0.82x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
-0.89x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
-1.15x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
0.86x
Caution
↓
Caution
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
2.45x
Excellent
↓
Excellent
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
6.02x
Excellent
Excellent
Free cash flow relative to reported net income
Optimal:
> 1x
|
0.35x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ |
|---|---|---|---|---|---|---|---|---|---|
| Return on Invested Capital (%) |
90.7%
Excellent
↑
Excellent
Improving
Return earned on debt + equity capital invested
Optimal:
> 10%
|
-180.1%
Weak
↓
Weak
Declining
Return earned on debt + equity capital invested
Optimal:
> 10%
|
-17.8%
Weak
↓
Weak
Declining
Return earned on debt + equity capital invested
Optimal:
> 10%
|
-16.7%
Weak
↓
Weak
Declining
Return earned on debt + equity capital invested
Optimal:
> 10%
|
-23.0%
Weak
↓
Weak
Declining
Return earned on debt + equity capital invested
Optimal:
> 10%
|
25.3%
Excellent
↓
Excellent
Declining
Return earned on debt + equity capital invested
Optimal:
> 10%
|
27.6%
Excellent
↓
Excellent
Declining
Return earned on debt + equity capital invested
Optimal:
> 10%
|
141.3%
Excellent
Excellent
Return earned on debt + equity capital invested
Optimal:
> 10%
|
-29.7%
Weak
Weak
Return earned on debt + equity capital invested
Optimal:
> 10%
|
| Return on Capital (%) (%) |
-0.8%
Weak
↓
Weak
Declining
Operating profit relative to total assets
Optimal:
> 10%
|
-0.7%
Weak
↓
Weak
Declining
Operating profit relative to total assets
Optimal:
> 10%
|
-0.2%
Weak
↑
Weak
Improving
Operating profit relative to total assets
Optimal:
> 10%
|
-0.2%
Weak
↑
Weak
Improving
Operating profit relative to total assets
Optimal:
> 10%
|
-0.4%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
-8.3%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
— | — | — |
| Return on Common Equity (%) (%) |
-31.3%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-360%)
|
97.5%
Excellent
↑
Excellent
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Above avg (+713%)
|
25.5%
Excellent
↑
Excellent
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Above avg (+112%)
|
20.8%
Excellent
↓
Excellent
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Above avg (+73%)
|
17.2%
Good
↓
Good
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Above avg (+43%)
|
32.0%
Excellent
↑
Excellent
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Above avg (+167%)
|
19.3%
Good
↑
Good
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Above avg (+61%)
|
29.7%
Excellent
Excellent
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Above avg (+147%)
|
-37.7%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-414%)
|
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ |
|---|---|---|---|---|---|---|---|---|---|
| Working Capital (USD) | $-196.69K | $179.24K | $587.80K | $719.92K | $871.82K | — | — | — | — |
| Total Equity (USD) | $-196.69K | $179.24K | $587.80K | $719.92K | $871.82K | $-52.09K | $-35.40K | $-23.04K | $18.16K |
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ |
|---|---|---|---|---|---|---|---|---|---|
| Net Income, GAAP (USD) | $61.47K | $174.84K | $149.80K | $149.80K | $149.80K | $-16.69K | $-6.84K | $-6.84K | $-6.84K |
| Operating Cash Flow (USD) | $-279.41K | $-154.56K | $-123.15K | $-132.70K | $-172.53K | $-14.28K | $-16.79K | $-41.20K | $-2.42K |
Secondary lens
Benchmark Lens
Benchmarks are disabled until comparison data is defensible.
Unavailable
Benchmark Lens
Benchmarks are disabled until comparison data is defensible.
Benchmarks unavailable
Verdicts use absolute quality thresholds, not peer comparison — only 0 comparable companies are currently available for ranking.
Use Statement Evidence firstCompare COLA with peers
Stack COLA against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago 2 years · 9 quarters